336 related articles for article (PubMed ID: 8212164)
1. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin.
Chen H; Wu J; Xu D; Luo H; Daloze PM
Transplantation; 1993 Sep; 56(3):661-6. PubMed ID: 8212164
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effects of mycophenolate mofetil and sirolimus in prevention of acute heart, pancreas, and kidney allograft rejection and in reversal of ongoing heart allograft rejection in the rat.
Vu MD; Qi S; Xu D; Wu J; Peng J; Daloze P; Sehgal S; Leduc B; Chen H
Transplantation; 1998 Dec; 66(12):1575-80. PubMed ID: 9884242
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of unresponsiveness to allografts induced by rapamycin and rapamycin/cyclosporine treatment in rats.
Ferraresso M; Ghobrial R; Stepkowski SM; Kahan BD
Transplantation; 1993 Apr; 55(4):888-94. PubMed ID: 8475565
[TBL] [Abstract][Full Text] [Related]
4. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel transplantation in the rat.
Stepkowski SM; Chen H; Daloze P; Kahan BD
Transplantation; 1991 Jan; 51(1):22-6. PubMed ID: 1987691
[TBL] [Abstract][Full Text] [Related]
5. Evidence that rapamycin rescue therapy delays rejection of major (MHC) plus minor (non-MHC) histoincompatible heart allografts in rats.
Wang ME; Stepkowski SM; Ferraresso M; Kahan BD
Transplantation; 1992 Oct; 54(4):704-9. PubMed ID: 1412762
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin reverses acute heart, kidney, and pancreas allograft rejection and prevents accelerated heart allograft rejection in the rat.
Chen H; Wu J; Xu D; Luo H; Daloze P
Transplant Proc; 1993 Feb; 25(1 Pt 1):719-20. PubMed ID: 8438454
[No Abstract] [Full Text] [Related]
7. Rapamycin inhibits production of cytotoxic but not noncytotoxic antibodies and preferentially activates T helper 2 cells that mediate long-term survival of heart allografts in rats.
Ferraresso M; Tian L; Ghobrial R; Stepkowski SM; Kahan BD
J Immunol; 1994 Oct; 153(7):3307-18. PubMed ID: 8089500
[TBL] [Abstract][Full Text] [Related]
8. 15AU81, a prostacyclin analog, enhances donor-specific hepatocytes to prolong the survival of rat heart but not small bowel allografts.
Boyle MJ; Dumble LJ
Cell Transplant; 1999; 8(5):543-8. PubMed ID: 10580348
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin.
Stepkowski SM; Chen HF; Wang ME; Daloze P; Kahan BD
Transplantation; 1992 Feb; 53(2):258-64. PubMed ID: 1738917
[TBL] [Abstract][Full Text] [Related]
10. Reversal of ongoing rejection of allografts by rapamycin.
Chen HF; Wu JP; Luo HY; Daloze PM
Transplant Proc; 1991 Aug; 23(4):2241-2. PubMed ID: 1871859
[No Abstract] [Full Text] [Related]
11. Synergistic interaction of 3 M KCl-extracted donor antigens (e-HAg) with cyclosporine or cyclosporine/sirolimus for prolongation of rat heart allograft survival.
Hamashima T; Stepkowski SM; Chou TC; Kahan BD
Transpl Immunol; 1995 Dec; 3(4):335-41. PubMed ID: 8665153
[TBL] [Abstract][Full Text] [Related]
12. Synergistic mechanisms by which sirolimus and cyclosporin inhibit rat heart and kidney allograft rejection.
Stepkowski SM; Tian L; Napoli KL; Ghobrial R; Wang ME; Chou TC; Kahan BD
Clin Exp Immunol; 1997 Apr; 108(1):63-8. PubMed ID: 9097913
[TBL] [Abstract][Full Text] [Related]
13. Effect of a short course of rapamycin, cyclosporin A, and donor-specific transfusion on rat cardiac allograft survival.
Davies CB; Madden RL; Alexander JW; Cofer BR; Fisher RA; Anderson P
Transplantation; 1993 May; 55(5):1107-12. PubMed ID: 8497890
[TBL] [Abstract][Full Text] [Related]
14. Long-term in vivo effects of rapamycin on humoral and cellular immune responses in the rat.
Chen H; Luo H; Daloze P; Xu D; Shan X; St-Louis G; Wu J
Immunobiology; 1993 Jul; 188(3):303-15. PubMed ID: 8225391
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive effects of the cyclosporin derivative SDZ IMM 125 on kidney allograft in the dog and small bowel and pancreas allografts in the rat.
Chen H; Qi S; Xu D; Bergeron E; Wu J; Beauregard-Zollinger L; Tan A; Daloze P
Clin Immunol Immunopathol; 1996 Jul; 80(1):76-81. PubMed ID: 8674242
[TBL] [Abstract][Full Text] [Related]
16. Intrasplenic liver parenchymal cells in conjunction with low-dose rapamycin and cyclosporine induce a unique and specific prolongation of rat cardiac and small bowel allograft survival.
Boyle MJ; Baghdassarian V; Stepkowski SM; Dumble LJ; Kahan BD
Cell Transplant; 1998; 7(3):247-56. PubMed ID: 9647434
[TBL] [Abstract][Full Text] [Related]
17. Combination therapy of mycophenolate mofetil and rapamycin in prevention of chronic renal allograft rejection in the rat.
Jolicoeur EM; Qi S; Xu D; Dumont L; Daloze P; Chen H
Transplantation; 2003 Jan; 75(1):54-9. PubMed ID: 12544871
[TBL] [Abstract][Full Text] [Related]
18. Protection against allograft rejection with intercellular adhesion molecule-1 antisense oligodeoxynucleotides.
Stepkowski SM; Wang ME; Condon TP; Cheng-Flournoy S; Stecker K; Graham M; Qu X; Tian L; Chen W; Kahan BD; Bennett CF
Transplantation; 1998 Sep; 66(6):699-707. PubMed ID: 9771832
[TBL] [Abstract][Full Text] [Related]
19. Immunosuppressive effects of FTY720 alone or in combination with cyclosporine and/or sirolimus.
Wang ME; Tejpal N; Qu X; Yu J; Okamoto M; Stepkowski SM; Kahan BD
Transplantation; 1998 Apr; 65(7):899-905. PubMed ID: 9565092
[TBL] [Abstract][Full Text] [Related]
20. Effects of rapamycin in experimental organ allografting.
Ochiai T; Gunji Y; Nagata M; Komori A; Asano T; Isono K
Transplantation; 1993 Jul; 56(1):15-9. PubMed ID: 8333037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]